Ibia E O, Schwartz R H, Wiedermann B L
Department of Infectious Diseases, Children's National Medical Center, Washington, DC, USA.
Arch Dermatol. 2000 Jul;136(7):849-54. doi: 10.1001/archderm.136.7.849.
To document the frequency and severity of various types of rashes seen with commonly used oral antibiotics in the pediatric outpatient setting.
A retrospective review of 5923 patient records at a pediatric office.
A private group pediatric practice in northern Virginia with about 12,000 registered active patients.
Approximately 50% of the clinic medical records were reviewed. All children (defined as those aged 0-18 years in this study) identified on their medical records as having developed a rash following treatment with 1 or more of the commonly used oral antibiotics were included in the study. For further validation, a questionnaire about parental recollection of description of rash, other associated symptoms, physician verification, and outcome was mailed to families with children designated as being allergic to an antibiotic.
On a prescription basis, significantly more rashes were documented for cefaclor (4.79%) compared with penicillins (2.72%), sulfonamides (3. 46%), and other cephalosporins (1.04%). Based on the number of patients for whom each group of antibiotic was prescribed, the documented frequencies of rashes were 12.3%, 7.4%, 8.5%, and 2.6% for cefaclor, penicillins, sulfonamides, and other cephalosporins, respectively. None of the children had rashes severe enough to require hospitalization.
In a review of almost 6000 records in a private pediatric primary care setting, rashes occurred in 7.3% of children who were given the commonly used oral antibiotics. Significantly more rashes were documented with cefaclor use than with use of any of the other oral antibiotics.
记录在儿科门诊环境中使用常用口服抗生素时出现的各类皮疹的频率和严重程度。
对一家儿科诊所的5923份患者记录进行回顾性研究。
弗吉尼亚州北部的一家私立儿科联合诊所,约有12000名注册在案的活跃患者。
约50%的诊所病历被纳入研究。所有在病历中被确定在用一种或多种常用口服抗生素治疗后出现皮疹的儿童(本研究中定义为年龄在0至18岁之间)均被纳入。为进一步验证,向被指定对某种抗生素过敏的儿童家庭邮寄了一份关于家长对皮疹描述、其他相关症状、医生核实及结果的回忆的问卷。
按处方计算,与青霉素(2.72%)、磺胺类药物(3.46%)和其他头孢菌素(1.04%)相比,头孢克洛记录的皮疹明显更多(4.79%)。根据每组抗生素的处方患者数量,头孢克洛、青霉素、磺胺类药物和其他头孢菌素记录的皮疹频率分别为12.3%、7.4%、8.5%和2.6%。没有儿童的皮疹严重到需要住院治疗。
在一家私立儿科初级保健机构对近6000份记录的回顾中,7.3%接受常用口服抗生素治疗的儿童出现了皮疹。使用头孢克洛记录的皮疹明显多于使用其他任何口服抗生素。